Nilotinib: Optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib

Ronan Swords, Devalingam Mahalingam, Swaminathan Padmanabhan, Jennifer Carew, Francis J. Giles

Resultado de la investigación: Review articlerevisión exhaustiva

24 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Nilotinib: Optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib'. En conjunto forman una huella única.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology

Nursing and Health Professions